Improvements in Glycemic Control Achieved by Altering the t(max) Setting in the iLet(®) Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial

INTRODUCTION: We investigated the safety of, and glucose control by, the insulin-only configuration of the iLet(®) bionic pancreas delivering fast-acting insulin aspart (faster aspart), using the same insulin-dosing algorithm but different time to maximal serum drug concentration (t(max)) settings,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Ther
Main Authors: Russell, Steven J., Balliro, Courtney, Ekelund, Magnus, El-Khatib, Firas, Graungaard, Tina, Greaux, Evelyn, Hillard, Mallory, Jafri, Rabab Z., Rathor, Naveen, Selagamsetty, Raj, Sherwood, Jordan, Damiano, Edward R.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266971/
https://ncbi.nlm.nih.gov/pubmed/34146238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01087-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados